Request Appointment
353 East 68th StreetNew York, NY 10065
Overview of Dr. Carlo
Dr. Maria Carlo is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Harvard Medical School and has been in practice 8 years. She is one of 517 doctors at Memorial Sloan Kettering Cancer Center and one of 87 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She also speaks multiple languages, including Spanish. She has more than 90 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
Harvard Medical SchoolClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2012 - 2028
NJ State Medical License 2020 - 2027
CT State Medical License 2023 - 2026
MA State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma.Lina Posada Calderon, Mark T Dawidek, Cerise Tang, Minsoo Kim, Grace Zong
European Urology. 2025-12-01 - MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma.Mark T Dawidek, Lina Posada Calderon, Parantu K Shah, Rohan Mittal, Burcin Agridag Ucpinar
European Urology. 2025-11-04 - Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6 / PMS2 -Associated Lynch Syndrome.Alicia Latham, Ying L Liu, Gillain Constantino, Matilde Borio, Sean McCoy
The American Journal of Gastroenterology. 2025-11-01
Press Mentions
Research at the Intersection of Oncology & GeneticsDecember 11th, 2019
Many Actionable Mutations May Be Missed in Current Testing of Advanced RCCJuly 9th, 2018
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
